Online Launch Event of NENs Updated Policy Recommendations 2022 on September 28th
INCA Board member Catherine Bouvier-Ellis, CEO & Co-Founder of Neuroendocrine Cancer UK, will take part is a presenter in the Launch Event of Neuroendocrine Neoplasms (NENs) Updated Policy Recommendations 2022: addressing Neuroendocrine Neoplasms cancer challenges...
Pheo Para Alliance supports the 6th International Symposium on Pheochromocytoma in October in Prague
The 6th International Symposium on Pheochromocytoma will be held on October 19-22nd, 2022, in Prague, Czech Republic. Worldwide experts in basic, clinical, and translational pheochromocytoma research will present their latest discoveries, guidelines, clinical trials...
NETRF Podcasts on NET Research
Advancing NET research is the core of NET Research Foundation (NETRF) mission, and it’s a crucial need, because NETs are extremely complicated cancers and there is still a lot the medical community needs to learn about them. This summer, NETRF launched two episodes of...
NeuroEndocrine Cancer Australia Contributes to Improving Referral Pathways from Regional Areas in Australia to NET Centres of Excellence
NeuroEndocrine Cancer Australia (NECA) is proud to have been part of the development of the Model of neuroendocrine cancer care (GEP-NETs), produced by the Gippsland Regional Integrated Cancer Service (GRICS) in collaboration with Peter MacCallum Cancer Centre (PMCC)...
Life in the Fast Lane: 2022 Video Series from the Carcinoid Cancer Foundation
The Carcinoid Cancer Foundation is excited to announce its 2022 video series beginning with “Life in the Fast Lane — The Eileen Bildman Story.” When Eileen “Red” Bildman was diagnosed with neuroendocrine cancer in 2017 little did she know how her life was going to...
Hope Foundation for Cancer Care Launches Fertility Information Platform for Cancer Patients in Taiwan
Hope Foundation for Cancer Care Taiwan is devoted to promote the reproductive rights of patients with cancer. The organization believes that every patient has the right to be informed and understand that being diagnosed with cancer does not necessarily mean...
AMEND CEO Elected to Co-chair the Patient Advisory Group of the European Society for Endocrinology
AMEND CEO, Jo Grey, has been elected as one of 3 co-chairs of the Patient Advisory Group (PAGs) Committee of the European Society for Endocrinology (ESE). Jo is delighted to join fellow co-chairs, Johan De Graaf (Chair of the Dutch Pituitary Foundation), and Peter...
INCA Welcomes LACNETS to Its Global Patient Advocacy Family
The Los Angeles Carcinoid Neuroendocrine Tumor Society (LACNETS) joins INCA to strengthen the global voice in support of NET patients. On behalf of all INCA, Mark McDonnell, INCA President, warmly welcomes LACNETS as the 32nd member of INCA: “We are happy that we can...
The Healing NET Foundation Joins the INCA Family
INCA welcomes its 31st member organization – The Healing NET Foundation, USA. Mark McDonnell, INCA President, extends a warm welcome to the Healing NET Foundation: “We are thrilled that we can join efforts in our dedication to raising NET awareness and driving change...
Neuroendocrine Cancer UK Presents “The Only Book I’ll Ever Write: When the Doctor Becomes the Patient”
In July 2022, Neuroendocrine Cancer UK shared insights and excerpts from a beautifully touching and honest book, "The Only Book I’ll Ever Write: When the Doctor Becomes the Patient”. It was written by a GP turned patient, Dr Paul Coffey. Paul wrote this powerful and...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
